Chemotherapy News and Research

Latest Chemotherapy News and Research

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

19 Feb 2011

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Scientists at the Children's Center for Cancer and Blood Diseases and The Saban Research Institute of Children's Hospital Los Angeles today announced a breakthrough discovery in understanding how the body fights leukemia.

18 Feb 2011

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Among a group of children's hospitals, nearly 20 percent of admissions and one-quarter of inpatient expenditures were accounted for by a small percentage of patients who have frequent recurrent admissions, according to a study in the February 16 issue of JAMA.

18 Feb 2011

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Apricus Biosciences, Inc., announced today that it is currently in discussions with the U.S. Food and Drug Administration ("FDA") relating to the PrevOnco™ Special Protocol Assessment ("SPA") Phase III protocol submitted by the Company in December 2010.

18 Feb 2011

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.

18 Feb 2011

Positive preliminary data from ongoing PSMA ADC phase 1 study against prostate cancer

Progenics Pharmaceuticals, Inc. today reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate designed to selectively deliver chemotherapy to cells that express prostate-specific membrane antigen.

17 Feb 2011

1000th clinical trial added to Cancer Research UK's patient information website

Cancer Research UK has added the 1000th clinical trial to its award winning patient information website, CancerHelp UK, on the 10th anniversary of the launch of its clinical trials database today.

17 Feb 2011

PMC to sponsor UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.

17 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

Continued smoking during radiation treatment for head and neck cancer affects prognosis

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

17 Feb 2011

FAK enzyme plays a key role in preparing lung tissue for metastatic development

A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.

17 Feb 2011

FDA, Threshold enter agreement on SPA for TH-302 Phase 3 trial in patients with soft tissue sarcoma

Threshold Pharmaceuticals, Inc. today announced that the Company reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a Phase 3 randomized trial of TH-302 in patients with soft tissue sarcoma.

17 Feb 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

17 Feb 2011

Smoking during radiation treatments reduces chance of overall survival

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology·Biology·Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

16 Feb 2011

Baldness cure by serendipity

Scientists at the University of California, Los Angeles were studying gut function but accidentally stumbled upon a five-day treatment that restored natural fur on bald laboratory mice.

16 Feb 2011

Passion for dancing helps beat breast cancer

When Karen Franklin was diagnosed with breast cancer last year, it was her passion for Zumba® that helped her beat the disease. Franklin's story, say experts at The University of Texas MD Anderson Cancer Center, reminds us about exercise's cancer-fighting benefits.

16 Feb 2011

Diagnosis of breast cancer in women over 70 leads to lower survival

Women over 70 are being diagnosed with breast cancer at a later stage leading to lower survival from the disease in the elderly, new research showed today (Wednesday).

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

AML patient raises awareness in community about national stem cell registry

By the age of 28, Dana Severson was already an Iraq war veteran, an accomplished clinical engineer, a wife and mother. Days following her daughter Genevieve's first birthday, Severson was faced with a reality that would turn her life upside down. After several weeks of experiencing severe headaches and extreme exhaustion, the young mother was diagnosed with acute myeloid leukemia.

16 Feb 2011

Researchers identify cell of origin for sarcoma

Researchers at Oregon Health & Science University Doernbecher Children's Hospital have defined the cell of origin for a kind of cancer called sarcoma. In a study published today as the Featured Article in the journal Cancer Cell, they report that childhood and adult sarcomas are linked in their biology, mutations and the cells from which these tumors first start.

16 Feb 2011

Chemotherapy News and Research

Latest Chemotherapy News and Research

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

Positive preliminary data from ongoing PSMA ADC phase 1 study against prostate cancer

1000th clinical trial added to Cancer Research UK's patient information website

PMC to sponsor UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Continued smoking during radiation treatment for head and neck cancer affects prognosis

FAK enzyme plays a key role in preparing lung tissue for metastatic development

FDA, Threshold enter agreement on SPA for TH-302 Phase 3 trial in patients with soft tissue sarcoma

Astellas, AVEO enter development, commercialization agreement for tivozanib

Smoking during radiation treatments reduces chance of overall survival

Baldness cure by serendipity

Passion for dancing helps beat breast cancer

Diagnosis of breast cancer in women over 70 leads to lower survival

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

AML patient raises awareness in community about national stem cell registry

Researchers identify cell of origin for sarcoma

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in